Market Signal Briefing

Inflows from major asset managers signal growing institutional confidence in digital assets and movement toward mainstream acceptance.

Photo: Yiğit Ali Atasoy

Key Takeaways

BlackRock and Fidelity's Bitcoin spot ETFs reached a combined trading volume of $5.5 billion in a single day.
BlackRock's IBIT dominates the spot Bitcoin ETF market with significant liquidity and inflows as of October 2025.

BlackRock and Fidelity’s spot Bitcoin ETFs recorded $5.5 billion in trading volume today, highlighting continued institutional interest in crypto assets.

BlackRock’s IBIT has emerged as a dominant force in spot Bitcoin ETFs, driving the majority of recent inflows and controlling significant liquidity as of early October 2025. The asset manager holds a notable portion of Bitcoin’s circulating supply through its ETF product.

Fidelity’s FBTC is actively contributing to capital cycling among spot Bitcoin ETFs, reflecting broader institutional accumulation strategies. In late September 2025, the investment firm demonstrated aggressive rotation of capital within the sector as institutional adoption of Bitcoin through spot ETFs continued to gain momentum.

Disclaimer

The crypto price prediction for these 3 altcoins has turned hugely positive, after Bitcoin hit a new all-time high yesterday.

Ethereum and Solana dominated investor interest, while altcoins like Sui and Chainlink also saw minor inflows.

Bitcoin attracted record-breaking inflows of $3.55 billion last week, even as its price neared historic highs and investors avoided short products. Across the broader digital asset market, investment inflows totaled $5.95 billion, which is the largest weekly inflows ever recorded.

CoinShares believes this surge indicates a delayed reaction to the FOMC’s interest rate reduction, coupled with disappointing employment figures from the ADP Payroll report and uncertainty surrounding US government stability due to the shutdown. The resulting price rally lifted total assets under management (AuM) in digital assets to a whopping $254 billion.

Investment Influx
According to the latest edition of the ‘Digital Asset Fund Flows Weekly Report,’ the bullish trend was widespread as Ethereum recorded $1.48 billion in inflows last week, bringing its year-to-date total to a record $13.7 billion, nearly triple last year’s figure. Solana also hit a new weekly record with $706.5 million in inflows, which pushed its YTD total to $2.58 billion. XRP attracted $219.4 million, while most other altcoins saw minimal investor activity.

Investment products dedicated to Sui, Chainlink, and Litecoin welcomed inflows of $3.4 million, $1.5 million, and $1.2 million in inflows respectively. Meanwhile, Cardano also saw a modest inflow of $0.5 million during the same period. Multi-asset products, on the other hand, was the only cohort to have bucked the trend as it saw a weekly outflow of $23.5 million.

Last week’s inflows showed broad regional optimism, with the United States leading the sentiment as it saw $5.0 billion inflows last week, a new weekly record. Switzerland also set a weekly high, posting $563 million in inflows, while Germany welcomed its second-largest weekly inflows of $312 million.

Next up were Canada, Australia, and Hong Kong with $32.1 million, $6.3 million, and $5 million in inflows, respectively. Brazil, too, settled with a minor $4.8 million in inflows. Sweden, in contrast, acted as an outlier with $8.6 million in outflows.

October Seasonality and Market Narratives
Going forward, QCP Capital predicted a strong but cautious outlook for Bitcoin as the market approaches a potential October breakout. According to its latest note, major whales appear to have either completed their asset rotations or are holding steady, and waiting for momentum to unfold.

You may also like:

XRP and Solana ETFs: Wall Street Validation or Decentralization Death Sentence?

No Gains for BTC in October? This AI Predicts Rangebound Price Action Between $108K and $123K

Why Ethereum (ETH) Could Be the Biggest Winner of the Global Liquidity Surge

Leveraged traders continue to chase the rally as BTC-PERP funding rates on major exchanges remain elevated, with 35% on Deribit and 29% on Hyperliquid, which points to aggressive positioning. However, such high perpetuals carry the risk of sharp liquidations, as seen two weeks ago when nearly $3 billion in long positions were wiped out, creating institutional entry opportunities.

In the options market, traders short on end-October calls have rolled strikes higher to 126k-128k as spot rallied. While some may view the recent BTC surge as excessive without clear catalysts, supportive narratives remain strong. For one, Bitcoin’s safe-haven appeal is reasserting itself amid the US government shutdown and outperforming gold, while October’s historically bullish seasonality adds fuel.

To top that, centralized exchange balances have fallen to six-year lows, yet another bullish indicator.

Tags:

Journalist

Posted: October 7, 2025

Key Takeaways
Why is Pi Network facing rug pull claims again?
It has plunged over 90%, erasing nearly $18 billion in market cap and fueling investor distrust.

What’s next for PI?
Without resolving community concerns and supply growth issues, the token could stay under pressure in the coming months.

Pi Network [PI] price has crashed over 90% since it debuted in March, renewing “rug pull” allegations. 

In March, the price shot up to $2.79 and reached about $18 billion in market cap amid FOMO after its debut. But it has slipped below $1 and dropped further to $0.26, shedding over $16 billion in market cap over the past six months. 

Source: CoinMarketCap

According to a pseudonymous crypto market commentator, Mr Spock, the 90% crash meant the project was a “rug pull.”

“Pi crashed over 90% from its highest position, that’s basically a rug pull.”

Hype and speculative interest fade
Back in May, PI faced a similar rug pull claim after the team allegedly created a $100 million venture fund amid unmet expectations and broken promises for over six years. 

The community felt that the $100 million fund, partly gained from internal revenue and mining, was diverted for external uses instead of the ecosystem. Unsurprisingly, the backlash capped the attempted rebound in May and dragged PI below $0.50. 

Despite the souring market sentiment on the altcoin, Pi Scan showed that some players were still accumulating it. 

In the past 24 hours, a Net Flow of $112.3 million was recorded, underscoring that more PI tokens flowed out of exchanges than into them, suggesting a buying spree. 

Source: Pi Scan

Derivatives data show speculative interest has collapsed
Even so, the speculative interest suggested otherwise. While there has been an improvement in Futures market demand, the overall speculative interest dropped by over 10X. 

Glassnode data showed that PI’s Open Interest (OI), or the number of opened contracts in the derivatives market, declined from nearly $120 million to about $20 million. 

Source: Glassnode

In other words, the altcoin has been under multi-month bearish pressure as the community felt sidelined by the team

The inflationary pressure also tanked the price. Since May, the PI’s circulating supply has increased by over 1 billion tokens. 

Source: Glassnode

Collectively, the unhappy PI community and distrust of the project team have left the altcoin under bearish drift. As a result, PI’s muted price action may continue for a while unless the team addresses community concerns. 

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

The price performance of multiple assets paints a mixed picture: it brings uncertainty for assets like XRP, Ethereum and Bitcoin. The most common picture right now is the rapid surge of selling pressure on multiple assets following the beginning of the trading week.

XRP's momentum coming to end?After forming what appears to be a head and shoulders pattern, a traditional bearish setup that frequently indicates the exhaustion of upward momentum, XRP may be headed toward a short-term correction.

The chart structure displays a head at approximately $3.70, a distinct left shoulder close to $3.20, and what now looks to be a growing right shoulder at approximately $3. A possible breakdown is typically preceded by such a formation, particularly if the asset is unable to sustain crucial support levels.

HOT Stories

XRP/USDT Chart by TradingViewThe market may be rejecting further bullish continuation, as the $3 threshold has now served as resistance three times. If the trend is confirmed, a close below this level might lead to a further decline toward the $2.80 or even $2.60 support zones, which are where the 100-day and 200-day moving averages converge.

Indicators of momentum at the moment support this prediction as well. After a brief spike, trading volume seems to be cooling off, and the RSI is neutral but flattening, suggesting a weakening in buying strength. This suggests that bulls are losing ground and that the market may be getting ready for a period of retracement.

The likelihood of a local top forming is still high unless XRP achieves a clear break above $3.10-$3.20, with strong volume confirmation. A decline below $2.80 would probably increase selling pressure if the head and shoulders pattern materializes, driving the asset toward its longer-term moving average support near $2.60, which has historically been a rebound point.

To put it briefly, the technical setup of XRP suggests that the recent recovery rally may be coming to an end. The bearish case is strengthened by the third consecutive denial at $3.  

Ethereum phase changeAs it consolidates just below the $4,500 level, which has served as both resistance and a psychological barrier in recent months, Ethereum looks to be entering a decisive phase.

Following a recovery from the $4,000-$4,100 support range, the asset has been rising steadily, and its most recent move indicates a clear intention to breach the crucial resistance level. ETH is currently trading close to $4,550, putting it up against the upper limit of a symmetrical triangle that has developed over the previous few weeks. Because it indicates a time of accumulation and equilibrium between buyers and sellers prior to the next significant move, this consolidation is a positive indication for the market.

The bullish outlook is strengthened by technical indicators that are trending upward, such as the 50-day and 100-day moving averages. Ethereum could confirm a breakout that could push the asset toward $5,000, which is in line with its previous all-time high zone, if it closes above the $4,500-$4,600 range with convincing volume. Based on the current market structure and indicators of recovering momentum, Ethereum appears to be steadily regaining strength and setting itself up for future gains.

Conversely, if momentum fails to hold above $4,500, the current rally on Bitcoin may cool off, and a short-term retest of support may occur at $4,300 or even $4,000. Higher lows have been steadily forming since late September, though, and the overall sentiment is still positive. Ethereum's consolidation now appears to be more of a springboard than a sign of exhaustion.

A strong breakout could ultimately push ETH toward the $5,000 mark, which many traders view as the next logical step in the ongoing recovery phase, provided market conditions hold and volume keeps increasing.

Bitcoin's pushAfter its recent surge, Bitcoin seems to be waning, which has some investors worried that the long-awaited push toward $150,000 might not come as soon as they had hoped.

The momentum behind Bitcoin appears to be weakening after a spectacular surge that propelled the largest cryptocurrency in the world over the $120,000 mark. Shorter time frames are showing early indications of exhaustion. A zone that usually precedes local pullbacks or at least periods of sideways consolidation, the daily RSI (Relative Strength Index) is currently above 70, indicating an overbought situation. Additionally, the trading volume has begun to decrease in comparison to the days of the previous surge, which may indicate that the buying pressure is waning.

Although its short-term strength seems stretched, Bitcoin’s technical structure is still bullish overall, supported by the 50- and 100-day moving averages. Before attempting another leg higher, Bitcoin may test support levels close to $120,000 or $115,000 due to the lack of fresh inflows and waning momentum. From a fundamental perspective, the long-term outlook is still supported by enthusiasm for institutional accumulation and ETF inflows.

Once early gains are made and the momentum slows, sentiment-driven rallies, however, frequently find it difficult to maintain their course. Now, traders are keeping an eye on whether Bitcoin can hold steady at its current levels without igniting a wider correction that might erode bullish sentiment.

Though it is becoming more obvious that new catalysts like resurgent institutional demand or macroeconomic shifts favoring riskier assets will be needed for the move, the path toward $150,000 may still be open if Bitcoin is able to consolidate above $120,000. Investors may need to lower their expectations for an instant breakout to new highs if momentum does not pick up soon.

Institutional Demand Drives Broader Rally
BTC, Ethereum (ETHETH), and Solana (SOL) have outperformed XRP in the current market breakout, given strong institutional demand through spot ETFs.

Pro-crypto lawyer Bill Morgan commented on XRP trailing the trio in the absence of an XRP-spot ETF market, stating:

“XRP is up but struggling to stay above $3 even though Bitcoin has reached another ATH. Bitcoin and Ethereum continue to enjoy a market advantage of spot ETFs having been approved while the SEC delays approving other altcoin ETFs. How long can the delay of spot XRP ETFs continue?”

Morgan also highlighted the performance of XRP against the US dollar, ETH, and BTC, underscoring the comparative strength of BTC, ETH, and SOL against XRP.

For the current month, XRP/BTC and XRP/ETH are down 3.85% and 7.12%, respectively, with SOL/XRP up 7.41%. Meanwhile, XRP has gained 5.38% against the US dollar.

Potential Catalysts for an XRP Breakout
Despite trailing BTC, ETH, and SOL, XRP could potentially outperform the three cryptos in October. Four XRP price catalysts include:

XRP-spot ETFs launch.
Ripple receives a banking license.
XRP utilization by global banks.
Senate passes the Market Structure Bill.

Although the Senate failed to pass the stopgap bill, approval could follow once funding resumes. XRP-spot ETFs may open the floodgates for Main Street investors looking for a crypto asset with real-world utility.

Given how ETF flows have driven BTC, ETH, and SOL higher, similar demand for XRP-spot ETFs could send the token to new highs. Standard Chartered Bank previously predicted XRP could break above $5 by December 2025 and climb to $12.5 by 2028.

For context, BTC has soared 169% since January 11, 2024, the first day of trading for US BTC-spot ETFs. A similar XRP-spot ETF trajectory would take XRP above $5.

Ripple’s Banking License and Legislative Momentum
However, XRP would likely also benefit from Ripple receiving a banking license, crypto legislation, increasing demand for Ripple’s XRPL, and global remittances.

Speculation has intensified over Ripple obtaining a US banking license since the public comment period ended. Meanwhile, updates on the Market Structure Bill continue to bolster sentiment despite the US government shutdown.

Crypto America host Eleanor Terrett shared the latest updates on the Market Structure Bill, stating:

“Senator Cory Booker has stepped in to lead bipartisan discussions on a crypto market structure draft for Democrats on the Senate Ag Committee, taking over from Ranking Member Senator Amy Klobuchar, according to several people familiar with the discussions. These talks are ongoing between Booker’s staff and Chairman John Boozman’s team, the people said. It remains unclear when a draft might be released. Booker, one of the senators from New Jersey, has long supported balanced crypto regulation and giving the CFTC greater authority over digital commodities.”

Why Traders Must Watch Capitol Hill
XRP soared 14.69% in response to the US House of Representatives passing the Market Structure Bill to the Senate. BTC gained just 0.39%, reflecting XRP’s sensitivity to US crypto legislation.

Price Action & Technical Analysis: Can Bulls Break $3 Resistance?
XRP advanced 0.68% on Monday, October 6, following the previous day’s 0.02% gain, closing at $2.9905. The token underperformed the broader market (1.68%) but briefly climbed above the psychological $3 level.

Traders are watching the following technical levels:

Support: $2.8, $2.5.
Resistance: $3, $3.1, $3.3, $3.66 (all-time high).

In the coming sessions, several key events could determine near-term price trends:

XRP ETF demand, crypto-spot ETF decisions (delays or launches), and BlackRock’s position on an iShares XRP Trust.
Blue-chip companies’ views on XRP as a treasury reserve asset.
Regulatory milestones: Ripple’s application for a US-chartered bank license, the Market Structure Bill, and SWIFT-related headlines would likely influence near-term price trends.

Catalysts & Scenarios
ETF flow trends, legislative headlines, banking license developments, and corporate demand for XRP as a treasury reserve asset will likely dictate price direction.

Bearish Scenario

GDLC, BITW, and XRPR ETFs report outflows, and BlackRock downplays plans for an XRP-spot ETF.
US government shutdown delays XRP-spot ETF approvals.
Lawmakers roadblock crypto-friendly regulations, such as the Market Structure Bill.
Blue-chip companies avoid XRP as a treasury reserve asset.
OCC delays or rejects Ripple’s US-chartered bank license.
SWIFT maintains global remittance dominance, limiting Ripple’s market access.

These bearish scenarios could push the token below $2.8, potentially testing the $2.5 support level.

Bullish Scenario

BITW, GDLC, and XRPR report strong inflows.
BlackRock files an S-1 for an iShares XRP Trust, and the SEC greenlights spot ETFs.
Blue-chip companies hold XRP for treasury purposes, and more payment platforms integrate Ripple technology.
Ripple secures a US-chartered bank license, and the Senate passes the Market Structure Bill.
SWIFT loses market share in the global remittance business to Ripple.

These bullish scenarios could drive the token toward $3.1. A sustained move through $3.1 would enable the bulls to target $3.3 and the all-time high of $3.66.

TXO Partners LP (TXO - Free Report) closed at $14.49 in the latest trading session, marking a +1.68% move from the prior day. This move outpaced the S&P 500's daily gain of 0.37%. On the other hand, the Dow registered a loss of 0.14%, and the technology-centric Nasdaq increased by 0.71%.

The company's stock has climbed by 5.01% in the past month, exceeding the Oils-Energy sector's gain of 2.31% and the S&P 500's gain of 4.26%.

Market participants will be closely following the financial results of TXO Partners LP in its upcoming release. The company is forecasted to report an EPS of $0.08, showcasing a 700% upward movement from the corresponding quarter of the prior year. Meanwhile, the latest consensus estimate predicts the revenue to be $99.66 million, indicating a 45% increase compared to the same quarter of the previous year.

For the full year, the Zacks Consensus Estimates project earnings of $0.23 per share and a revenue of $387.8 million, demonstrating changes of -64.62% and +37.12%, respectively, from the preceding year.

Investors should also take note of any recent adjustments to analyst estimates for TXO Partners LP. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.

Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. TXO Partners LP is holding a Zacks Rank of #5 (Strong Sell) right now.

Digging into valuation, TXO Partners LP currently has a Forward P/E ratio of 61.96. Its industry sports an average Forward P/E of 12.4, so one might conclude that TXO Partners LP is trading at a premium comparatively.

The Energy and Pipeline - Master Limited Partnerships industry is part of the Oils-Energy sector. With its current Zacks Industry Rank of 215, this industry ranks in the bottom 13% of all industries, numbering over 250.

The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.

Kraft Heinz (KHC - Free Report) closed the most recent trading day at $25.27, moving -3.03% from the previous trading session. This move lagged the S&P 500's daily gain of 0.37%. Elsewhere, the Dow saw a downswing of 0.14%, while the tech-heavy Nasdaq appreciated by 0.71%.

Coming into today, shares of the processed food company with dual headquarters in Pittsburgh and Chicago had lost 4.51% in the past month. In that same time, the Consumer Staples sector lost 3.28%, while the S&P 500 gained 4.26%.

Investors will be eagerly watching for the performance of Kraft Heinz in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be $0.58, reflecting a 22.67% decrease from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $6.27 billion, indicating a 1.72% decline compared to the corresponding quarter of the prior year.

KHC's full-year Zacks Consensus Estimates are calling for earnings of $2.58 per share and revenue of $25.24 billion. These results would represent year-over-year changes of -15.69% and -2.35%, respectively.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Kraft Heinz. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.

The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.16% decrease. Kraft Heinz is holding a Zacks Rank of #3 (Hold) right now.

With respect to valuation, Kraft Heinz is currently being traded at a Forward P/E ratio of 10.11. This signifies a discount in comparison to the average Forward P/E of 16.05 for its industry.

Also, we should mention that KHC has a PEG ratio of 3.04. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Food - Miscellaneous was holding an average PEG ratio of 1.74 at yesterday's closing price.

The Food - Miscellaneous industry is part of the Consumer Staples sector. This group has a Zacks Industry Rank of 174, putting it in the bottom 30% of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.

Sweetgreen, Inc. (SG - Free Report) closed at $7.93 in the latest trading session, marking a -3.76% move from the prior day. This change lagged the S&P 500's daily gain of 0.37%. On the other hand, the Dow registered a loss of 0.14%, and the technology-centric Nasdaq increased by 0.71%.

Coming into today, shares of the company had lost 7.73% in the past month. In that same time, the Retail-Wholesale sector gained 0.38%, while the S&P 500 gained 4.26%.

Market participants will be closely following the financial results of Sweetgreen, Inc. in its upcoming release. The company's upcoming EPS is projected at -$0.16, signifying a 11.11% increase compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $183.58 million, reflecting a 5.85% rise from the equivalent quarter last year.

For the full year, the Zacks Consensus Estimates are projecting earnings of -$0.71 per share and revenue of $713.85 million, which would represent changes of +10.13% and +5.47%, respectively, from the prior year.

Investors should also pay attention to any latest changes in analyst estimates for Sweetgreen, Inc. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.48% lower. At present, Sweetgreen, Inc. boasts a Zacks Rank of #4 (Sell).

The Retail - Restaurants industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 194, putting it in the bottom 22% of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

Pacific Biosciences of California (PACB - Free Report) ended the recent trading session at $1.52, demonstrating a +2.01% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily gain of 0.37%. Elsewhere, the Dow saw a downswing of 0.14%, while the tech-heavy Nasdaq appreciated by 0.71%.

Prior to today's trading, shares of the maker of genetic analysis technology had gained 17.32% outpaced the Medical sector's gain of 5.9% and the S&P 500's gain of 4.26%.

Analysts and investors alike will be keeping a close eye on the performance of Pacific Biosciences of California in its upcoming earnings disclosure. The company is predicted to post an EPS of -$0.16, indicating a 5.88% growth compared to the equivalent quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $40.38 million, indicating a 1.03% growth compared to the corresponding quarter of the prior year.

Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.6 per share and revenue of $158.75 million. These totals would mark changes of +27.71% and +3.07%, respectively, from last year.

Investors should also take note of any recent adjustments to analyst estimates for Pacific Biosciences of California. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.

The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.84% lower within the past month. Pacific Biosciences of California is currently a Zacks Rank #3 (Hold).

The Medical - Instruments industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 144, positioning it in the bottom 42% of all 250+ industries.

The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.

Hyster-Yale (HY - Free Report) closed at $36.06 in the latest trading session, marking a -1.8% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.37% for the day. Elsewhere, the Dow saw a downswing of 0.14%, while the tech-heavy Nasdaq appreciated by 0.71%.

Shares of the maker of lift trucks and aftermarket parts have depreciated by 2.6% over the course of the past month, underperforming the Industrial Products sector's gain of 3.99%, and the S&P 500's gain of 4.26%.

Investors will be eagerly watching for the performance of Hyster-Yale in its upcoming earnings disclosure. The company is expected to report EPS of $0.03, down 96.91% from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $955.69 million, showing a 5.95% drop compared to the year-ago quarter.

For the full year, the Zacks Consensus Estimates project earnings of $0.75 per share and a revenue of $3.77 billion, demonstrating changes of -91.65% and -12.59%, respectively, from the preceding year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Hyster-Yale. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Currently, Hyster-Yale is carrying a Zacks Rank of #5 (Strong Sell).

In terms of valuation, Hyster-Yale is presently being traded at a Forward P/E ratio of 48.96. This indicates a premium in contrast to its industry's Forward P/E of 24.42.

The Manufacturing - Construction and Mining industry is part of the Industrial Products sector. This industry, currently bearing a Zacks Industry Rank of 208, finds itself in the bottom 16% echelons of all 250+ industries.

The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

Luminar Technologies, Inc. (LAZR - Free Report) closed at $2.24 in the latest trading session, marking a -8.57% move from the prior day. This change lagged the S&P 500's daily gain of 0.37%. On the other hand, the Dow registered a loss of 0.14%, and the technology-centric Nasdaq increased by 0.71%.

Shares of the company have appreciated by 47.59% over the course of the past month, outperforming the Auto-Tires-Trucks sector's gain of 17.2%, and the S&P 500's gain of 4.26%.

The investment community will be closely monitoring the performance of Luminar Technologies, Inc. in its forthcoming earnings report. It is anticipated that the company will report an EPS of -$1.08, marking a 55% rise compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $17.59 million, up 13.56% from the prior-year quarter.

In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of -$4.5 per share and a revenue of $69.91 million, indicating changes of +51.3% and -7.28%, respectively, from the former year.

Investors might also notice recent changes to analyst estimates for Luminar Technologies, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.

The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Currently, Luminar Technologies, Inc. is carrying a Zacks Rank of #3 (Hold).

The Automotive - Original Equipment industry is part of the Auto-Tires-Trucks sector. Currently, this industry holds a Zacks Industry Rank of 83, positioning it in the top 34% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.

Archer Daniels Midland (ADM - Free Report) closed the most recent trading day at $62.45, moving +2.31% from the previous trading session. This move outpaced the S&P 500's daily gain of 0.37%. On the other hand, the Dow registered a loss of 0.14%, and the technology-centric Nasdaq increased by 0.71%.

Shares of the agribusiness giant have depreciated by 3.02% over the course of the past month, outperforming the Consumer Staples sector's loss of 3.28%, and lagging the S&P 500's gain of 4.26%.

The investment community will be paying close attention to the earnings performance of Archer Daniels Midland in its upcoming release. The company's earnings per share (EPS) are projected to be $0.87, reflecting a 20.18% decrease from the same quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $20.17 billion, showing a 1.18% escalation compared to the year-ago quarter.

ADM's full-year Zacks Consensus Estimates are calling for earnings of $3.99 per share and revenue of $83.75 billion. These results would represent year-over-year changes of -15.82% and -2.09%, respectively.

Investors should also pay attention to any latest changes in analyst estimates for Archer Daniels Midland. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability.

Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.

The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. At present, Archer Daniels Midland boasts a Zacks Rank of #3 (Hold).

Looking at its valuation, Archer Daniels Midland is holding a Forward P/E ratio of 15.28. This indicates no noticeable deviation in contrast to its industry's Forward P/E of 15.28.

It is also worth noting that ADM currently has a PEG ratio of 3.25. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The average PEG ratio for the Agriculture - Operations industry stood at 1.77 at the close of the market yesterday.

The Agriculture - Operations industry is part of the Consumer Staples sector. At present, this industry carries a Zacks Industry Rank of 150, placing it within the bottom 40% of over 250 industries.

The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.

, /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Fly-E Group, Inc. ("Fly-E" or the "Company") (NASDAQ: FLYE).

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN FLY-E GROUP, INC. (FLYE), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE NOVEMBER 7, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at [email protected], by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Is The Lawsuit About?
The complaint filed alleges that, between July 15, 2025 and August 14, 2025, Defendants failed to disclose to investors that: (1) the Defendants continually praised Fly-E's brand reputation in the industry, cost reductions and favorable pricing from suppliers as a key component for Fly-E's ability to grow its sales network, while simultaneously minimizing risks associated with its lithium battery, supply chain changes and the regulatory environment and possible demand fluctuations for its E-Bikes and E-Scooters; and (2) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Contact Us To Participate or Learn More: 
If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact:
Howard G. Smith, Esq.,
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Call us at: (215) 638-4847
Email us at: [email protected],
Visit our website at: www.howardsmithlaw.com.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us: 
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
[email protected]
www.howardsmithlaw.com

SOURCE Law Offices of Howard G. Smith

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

, /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Charter Communications, Inc. ("Charter" or the "Company") (NASDAQ: CHTR) have opportunity to lead the securities fraud class action lawsuit.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CHARTER COMMUNICATIONS, INC. (CHTR), CLICK HERE BEFORE OCTOBER 14, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

 What Is The Lawsuit About?
The complaint filed alleges that, between July 26, 2024 and July 24, 2025, Defendants failed to disclose to investors that: (1) the impact of the ACP end was a material event the Company was unable to manage or promptly move beyond; (2) the ACP end was actually having a sustaining impact on Internet customer declines and revenue; (3) neither was the Company executing broader operations in a way that would compensate for, or overcome the impact, of the ACP ending; (4) the Internet customer declines and broader failure of Charter's execution strategy created much greater risks on business plans and earnings growth than reported; (5) accordingly, the Company had no reasonable basis to state the Company was successfully executing operations, managing causes of Internet customer declines, or provide overly optimistic statements about the long term trajectory of the Company and EBITDA growth; and (6) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Contact Us To Participate or Learn More: 
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
The Law Offices of Frank R. Cruz,
Email us at: [email protected]
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com
Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SOURCE The Law Offices of Frank R. Cruz, Los Angeles

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

-

MILPITAS, Calif.--(BUSINESS WIRE)--Sandisk Corporation (NASDAQ: SNDK) announced today that it will hold its fiscal first quarter earnings conference call on Thursday, November 6, 2025, at 1:30 p.m. Pacific Time.

A live webcast and a webcast replay of the conference call will be available at investor.sandisk.com.

About Sandisk

Sandisk (Nasdaq: SNDK) delivers innovative Flash solutions and advanced memory technologies that meet people and businesses at the intersection of their aspirations and the moment, enabling them to keep moving and pushing possibility forward. Follow Sandisk on Instagram, Facebook, X, LinkedIn, YouTube. Join TeamSandisk on Instagram.

Sandisk and the Sandisk logo are registered trademarks or trademarks of Sandisk Corporation or its affiliates in the U.S. and/or other countries.

© 2025 Sandisk Corporation or its affiliates. All rights reserved.

More News From Sandisk Corporation

Back to Newsroom

SINGAPORE, Oct. 06, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Verde AgriTech Ltd. (TSX: NPK | OTCQX: VNPKF), please note: we updated the Appendix table to correct a presentation alignment. The column headings list the individual oxides in alphabetical order, followed by TREO and MREO; the data had appeared in the reverse order, which misaligned values with their headings. This update does not change the underlying assays or calculations. No changes were made to TREO, MREO, or individual rare earth element totals or interpretations; the update is limited to table alignment. The corrected Appendix follows. All other content remains unchanged.

Continuous clay-hosted REE mineralised zone outlined.

High-grade NdPr-rich samples return up to 8,930 ppm TREO and 2,182 ppm MREO.

22 samples return > 1,000 ppm MREO

Verde AgriTech Ltd. (TSX: NPK | OTCQX: VNPKF) ("Verde” or the “Company”), announces the delineation of a continuous clay hosted rare earth element (“REE”) mineralized zone (“the Zone”) in Alto Paranaíba, Minas Gerais, Brazil, covering ~5,500 hectares (or ~20 square miles) across 13 mineral rights. The Zone was delineated by integrated geological mapping, geochemistry and spectral/geophysical datasets, and confirmed by trench sampling.

Exploration Highlights:

High-grade magnet rare earth tenor across a broad sample base: 75 surface/trench samples average magnetic rare earth oxides (“MREO”) 743 ppm, with 54/75 ≥400 ppm, 22/75≥1,000 ppm and 7/75 ≥1,500 ppm MREO.Total rare earths at meaningful surface tenor: Total rare earth oxides (“TREO”) averages 3,532ppm, median 3,148, with peak assays up to 8,930 ppm and 2,182 ppm MREO.Heavy rare earths confirmed: Top 10 MREO samples carry dysprosium oxide ~35–60 ppm and terbium oxide ~8–13 ppm, reinforcing high coercivity magnet potential alongside NdPr (see Table 1).Magnet critical balance: Neodymium and praseodymium (NdPr) typically contribute on average ~19% of TREO within the samples tested, peaking at 24%, with dysprosium and terbium present in higher grade samples — supportive of high coercivity magnet feed.Near-term catalyst: Given the significance of the discovery and potential economics, Verde’s Board of Directors is conducting a formal review and will communicate next steps within seven days. “This discovery demonstrates a rare earth mineralized zone of considerable size and coherence across our mineral rights. The combination of TREO and MREO enrichment highlights a compelling growth opportunity,” commented Cristiano Veloso, Founder and CEO. “We are now preparing to advance the project through a Board review to identify the best path forward to unlocking the project’s full potential.”

Table 1: Top 10 samples by MREO (incl. TREO, Nd, Pr, Dy, Tb)

Channel
From
To
UTMN
UTME
Oxide Total Grade (ppm)TREOMREODy2O3Nd2O3Pr6O11Tb4O7PT-34127841160.46384496.158615218260164446413PT-34017841160.46384496.158930211853159246112PT-08017863699.87401672.168276181648133042811PT-12017871455.52404413.967669170546125139810PT-18127865477.78404446.447202167646123138910PT-36017845380.34384873.08718115933711983509PT-21127867642.38405141.507250150749110234710PT-45017856478.40382570.77641813723710263008PT-05017862246.40401300.4861611327359723138
MREO—dominated by NdPr, with contributions from Dy and Tb—is the core feedstock for high performance permanent magnets used in EV drivetrains, wind turbines and advanced electronics. A coherent, near surface footprint with consistent NdPr tenor is a key early indicator for scale and relevance in the REE value chain.

Beyond the strong NdPr tenor, Verde’s assays demonstrate consistent enrichment in the heavy rare earths dysprosium (Dy) and terbium (Tb) that underpin high temperature, high coercivity magnets. In the 10 highest grade MREO trench samples (1,306–2,182 ppm MREO; 6,081–8,930 ppm TREO), dysprosium oxide ranges 35–60 ppm and terbium oxide 8–13 ppm, with standout samples at trench PT-34 pairing >2,100 ppm MREO with dysprosium oxide 53–60 ppm and terbium oxide 12–13 ppm. This persistent Dy/Tb presence alongside elevated NdPr strengthens the overall magnet rare earth basket quality.

The 13 mineral claims are held by Verde and overlap with the Company’s potash resources, which have been a part of the portfolio for more than a decade.

Figure 1: Map of the Mineralized Zone

Board Review and Next Steps

Given the significance of this discovery and its potential economics—and mindful of Verde’s primary mission as a fertilizer company—the Board of Directors has initiated a formal review to determine the optimal path forward, balancing disciplined capital allocation with strategic alternatives, including targeted drilling, staged evaluation, partnerships, or other structures that preserve focus on core operations while maximizing value. As part of this process, the Board welcomes shareholder feedback through the Company’s investor relations channels and expects to issue a comprehensive update and go forward plan within the next seven days (on or before October 13, 2025).

Qualified Person

The scientific and technical information contained in this news release has been reviewed and approved by José Márcio Matta Machado Paixão, Fellow AusIMM, who is a Qualified Person for exploration results under National Instrument 43-101, Standards of Disclosure for Mineral Projects.

QAQC

Analyses were performed by SGS Geosol (Vespasiano, Brazil) using lithium-borate fusion with ICP-MS/OES (IMS95A/ICP95A method). The QA/QC program inserted 3 blanks, 3 certified reference materials (CRMs) and 3 field duplicates among 84 total submissions. Relative to the 75 primary samples (SMP), control insertion equates to 12% (each control type 4% vs. SMP count). Analytical performance was monitored using Ce, Dy, La, Nd, Pr, and Y, consistent with JORC-aligned practice.

This news release presents exploration results and does not constitute a mineral resource or reserve estimate. Forward-looking statements are subject to risks and uncertainties, and actual results may differ materially.

About Verde AgriTech

Verde AgriTech is dedicated to advancing sustainable agriculture through the innovation of specialty multi nutrient potassium fertilizers. Our mission is to increase agricultural productivity, enhance soil health, and significantly contribute to environmental sustainability. Utilizing our unique position in Brazil, we harness proprietary technologies to develop solutions that not only meet the immediate needs of farmers but also address global challenges such as food security and climate change. Our commitment to carbon capture and the production of eco-friendly fertilizers underscores our vision for a future where agriculture contributes positively to the health of our planet. For more information on how we are leading the way towards sustainable agriculture and climate change mitigation in Brazil, visit our website: https://verde.ag/en/home.

Cautionary Language and Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation, including, but not limited to, statements with respect to: the significance of exploration results; the potential for economic extraction of rare earth elements; future exploration and development plans; the outcome of the Board of Directors’ review; potential partnerships, strategic alternatives, or value-maximizing structures; the advancement of the project; and the expected timing of further updates. Forward-looking information is based on management’s current expectations, assumptions, estimates, projections, and interpretations, and involves known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those expressed or implied. These factors include, without limitation: risks related to exploration stage projects; the possibility that future exploration results may not support mineral resource or reserve delineation; uncertainties relating to assay and metallurgical results; operational risks inherent in mining; risks associated with maintaining licenses, permits and mineral rights; changes in laws, regulations and government policies; risks related to capital and operating costs; commodity price volatility; financing risks; and other risks described in the Company’s most recent annual information form and other continuous disclosure filings available under the Company’s profile at www.sedarplus.ca .

Readers are cautioned not to place undue reliance on forward-looking information. The Company does not undertake to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required under applicable securities laws.

This news release reports exploration results which are preliminary in nature and do not represent mineral resources or mineral reserves as defined under National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”). There is no certainty that further exploration will result in the delineation of mineral resources, mineral reserves, or that any development decision will be made. Mineralization identified to date is not necessarily indicative of future results.

For additional information please contact:

Cristiano Veloso, Chief Executive Officer and Founder

Tel: +55 (31) 3245 0205; Email: [email protected]

www.verde.ag | www.investor.verde.ag

Appendix

Sample IDTrench_IDFromToUTMNUTMECeO2Dy2O3Er2O3Eu2O3Gd2O3Ho2O3La2O3Lu2O3Nd2O3Pr6O11Sm2O3Tb4O7Tm2O3Y2O3Yb2O3TREOMREO%NdPrOB01PT-01017860136,93399395,0811391661332245113581155431654226049321%OB02PT-01127860136,93399395,0812071761332248213781215741685239552121%OB03PT-01237860136,93399395,0811411651330245113471135331604223947921%OB04PT-01347860136,93399395,0811371661330244703491125231614223147921%OB05PT-02017860008,24399670,4114781861839361914911436941604295365721%OB06PT-02127860008,24399670,4113401961841357814891407141634277765323%OB07PT-02237860008,24399670,4110631451228243503501025231473211646921%OB08PT-03017860373,94399292,905749471712600198652920383120927422%OB09PT-03127860373,94399292,9069910481812930223663220363139630121%OB10PT-04017860344,16399720,8411941551432246803871245831533235852922%OB11PT-04127860344,16399720,8413111651535251604231356141573258557722%OB12PT-05017862246,40401300,48301535936824143619723131438110456161132721%OB13PT-06017863968,97400492,1027882572450395416812279851786494893818%OB14PT-07017863592,35401682,6913311651432250203941285731583254954120%OB15PT-08017863699,87401672,164010481447108619041133042819211116788276181621%OB16PT-09017863583,94401415,281043146102524251286884131524200039019%OB17PT-10017873694,77404024,0214871241124254313501234721504266148818%OB18PT-11017871366,77404423,6522902682760410641791229110618354704105222%OB19PT-12017871455,52404413,963718461444101617171125139818210217197669170521%OB20PT-13017871485,92404344,3221582172145381416012018351795404482820%OB21PT-14017865827,87403058,242971371135785139619553061378113476081130621%OB22PT-15017866820,89404291,86216727924574798168121310161966419092721%OB26PT-15127866820,89404291,8612151661433243703861205731634235752521%OB27PT-16017866556,86404506,8713271661432252213861265631664256253220%OB28PT-17017866258,13404800,7880912592223371249733621504161333720%OB29PT-18017865477,78404446,443183341032724133918832901297111066102121419%OB30PT-18127865477,78404446,443326461445103616701123138917910117387202167622%OB31PT-18237865477,78404446,44269832931694126318612791257111155497117921%OB32PT-19017865657,08404535,962749321032724124418652771317111175544118121%OB34PT-19127865657,08404535,962664311029674123818032671167110765351110820%OB37PT-20017865452,76404324,042817361232745125918832821327113885688120920%OB38PT-20127865452,76404324,042949361132745126118832841318112975811121020%OB39PT-21017867642,38405141,503129401335835133619533051398115486211130620%OB40PT-21127867642,38405141,503731491741997145611102347168102209117250150720%OB41PT-22017867679,28405045,33103513692323721239803631624188533517%OB42PT-23017868499,58405216,072555341033744127319072881337111965447123622%OB43PT-24017868992,10405763,2783912582123821255783621594170634720%OB44PT-25017869012,94405715,3880010481923230231703221413154631320%OB45PT-26017838552,42385327,429776241012350132431810212145118212%OB46PT-27017838674,70385289,6025771147202514023577292145335273259%OB47PT-28017840193,99390174,292962213058033114001424264610%OB48PT-29017840174,77388865,5139442251112061208101626278513%OB49PT-30017839685,23388198,799405326115217326101033312561058%OB50PT-31017839259,62386861,33675321316603612500182826526%OB51PT-32017839840,68386591,947633214110704917710172974707%OB52PT-33017841236,73384705,4318211961838379605891827541594361479421%OB53PT-34017841160,46384496,154083531554126721041159246121412120078930211823%OB54PT-34127841160,46384496,153636601757135821081164446422113224088615218224%OB55PT-35017844181,84382675,5216691861740367315441587341715328272421%OB56PT-36017845380,34384873,0835633711398751570111983501589114667181159322%OB57PT-37017846622,38384552,663876438114519529131134473013217%OB58PT-38017846381,08383737,97648744911991114371511404108616014%OB59PT-39017845628,31383624,1116752271741360514581346741874312661919%OB60PT-40017853691,01385824,6523212372149388716541978751825434287920%OB61PT-41017853450,63385544,70402833101235113644181137490318920%OB65PT-42017854988,06383520,7721693192970498218232351167112254605109623%OB66PT-43017854599,80383201,6532112682758312881879270115618255980118119%OB67PT-44017856215,69381334,7437863381160110332141032374714218%OB68PT-45017856478,40382570,7731823713348061402110263001378218096418137221%OB69PT-46017855995,63384092,1911121551229243003351004931513214845320%OB70PT-47017856236,70384223,7616391761634265015171546931545316969121%OB71PT-48017857095,05388484,46251230927614984172221110561957477596920%OB72PT-49017857168,36388409,6523252271841373615221567541805399870417%OB73PT-50017857512,64389654,981071134112623910319864330443201742120%OB74PT-51017857653,49389592,3012751861538349814221106041674251955321%OB75PT-52017857805,93389535,7715591861638267714871346641605307564420%OB76PT-53017876853,68404424,6417411651535265904681336241513319662119%OB77PT-54017858794,38395057,1216832171945374815611507841675339173621%OB78PT-55017858742,42394780,552939311030714120119072441237110565679118920%OB79PT-56017861579,61396138,1318342372150382216271698551805373382421%OB80PT-57017857196,72397136,2316972162147379706061628151684351979422%OB81PT-58017859362,65397072,9016502372253387216461708851845363084522%OB82PT-59017859626,95397185,891914214153039116102333385415%OB83PT-60017888465,33407537,876845241012160136411810192113918316%OB84PT-61017887899,46406517,431773124065045136001213326218%

Figures accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/71208c83-3f8c-4134-b120-a850ef4ab93a

https://www.globenewswire.com/NewsRoom/AttachmentNg/10e0650d-c6c0-4cce-a9c1-09a361df31d3

Eli Lilly and Company Today

LLY

Eli Lilly and Company

$845.40 +5.53 (+0.66%)

As of 03:59 PM Eastern

52-Week Range$623.78▼

$937.00Dividend Yield0.71%

P/E Ratio55.25

Price Target$938.94

After tanking in early August, the world’s most valuable pharmaceutical stock has roared back with a vengeance. That firm is Eli Lilly and Company NYSE: LLY, the maker of the wildly popular weight loss and diabetes drugs Zepbound and Mounjaro. During the trading week ending Oct. 3, the stock surged by 16%, reaching its highest level since April.

This comes after Lilly shares plummeted by over 14% on Aug. 7, even though its Q2 release that day crushed expectations. However, the simultaneous release of disappointing clinical trial results for its oral GLP-1, orforglipron, led shares to plummet. MarketBeat pointed out at that time that this could be a fruitful buy-the-dip opportunity. Since that 14% fall, the stock is up more than 31% year-to-date. Notably, around half of this gain came recently, driven by an all-important development: Pfizer’s NYSE: PFE tariff deal. Below, we’ll break down exactly what drove the highly impressive run-up in Lilly shares and what's next.

Get Eli Lilly and Company alerts:

Trump, Pfizer, and Lilly: Why Tariff Resolutions Are Driving Shares Higher
On Sept. 25, President Trump announced that companies importing branded pharmaceuticals to the United States would face a 100% tariff. However, Trump would spare companies that invest in U.S. manufacturing facilities. Still, with limited details and most pharma firms already having manufacturing investments in the United States, it wasn’t clear who would actually be exempt. This uncertainty left shares of big pharma stocks relatively unchanged on Sept. 26.

Clarity then emerged on Sept. 30 and Oct. 1, after Pfizer announced that it had reached a deal with the Trump administration. By lowering its drug prices and committing to further U.S. investments, the company would gain a three-year exemption from tariffs.

Eli Lilly shares got huge boosts on those days, rising 5% on Sept. 30 and 8% on Oct. 1. This was due to the realization that Lilly could also avoid tariffs through a similar arrangement. Additionally, financial media outlets reported that Lilly was the next company in line to strike a deal with Trump.

Notably, Lilly has been intelligently preparing for the threat of lofty pharma tariffs in 2025, as Trump has alluded to this possibility multiple times. In February, the company announced that it would increase its investment in U.S. manufacturing by $27 billion. Chief Executive Officer David Ricks also recently said Lilly would become a net exporter of injectable GLP-1s from the United States. Overall, these factors position Lilly to strike a tariff-avoiding deal, leading to the robust rise in shares.

 Lilly Can Protect Key Markets Despite Coming Concessions
Although Lilly looks poised to avoid highly burdensome tariffs, a potential deal with Trump will not come without costs. For example, as a term of Pfizer’s deal, the company says it will cut its U.S. drug prices by an average of 50%. Although this may get the tariff monkey off its back, it clearly translates into lower revenues. However, Pfizer only seems to be making new pricing concessions in direct-to-consumer (DTC) and Medicaid pharmaceutical spending.

Overall MarketRank™100th Percentile

Analyst RatingModerate Buy

Upside/Downside11.1% Upside

Short Interest LevelHealthy

Dividend StrengthStrong

Environmental Score-2.25

News Sentiment1.25 Insider TradingAcquiring Shares

Proj. Earnings Growth32.54%

See Full Analysis

These channels are two of the smallest in the United States. In 2023, DTC accounted for only 13% of drug sales, while Medicaid accounted for 11%. Meanwhile, Medicare and private health insurance accounted for a combined 71% of spending. So, if Lilly strikes a deal similar to Pfizer’s, it is likely to protect pricing on the vast majority of its sales.

Additionally, data from Real Chemistry indicates that Medicaid spent only around $200 million combined on Zepbound and Mounjaro in 2024. That’s a drop in the bucket compared to the over $24 billion in sales these drugs combined for in the last 12 months. Thus, Medicaid concessions could have a nearly negligible impact on the sale of Lilly’s two blockbusters. Lilly also said in February that its DTC channel, Lilly Direct, accounted for a single-digit percentage of total Zepbound prescriptions. This further supports the point of Lilly protecting its key markets.

LLY’s Upswing Could Have Further Room to Run
Overall, it appears that a Pfizer-like deal would be a huge win for Eli Lilly. It would be more than worth mitigating the threat of onerous tariffs that have cast a dark cloud over the pharma industry for some time. The MarketBeat consensus price target for Lilly is approximately $933, indicating about 11% potential upside. With a potential Trump deal as a catalyst, and tariffs becoming a fading concern, there is a significant chance Lilly’s strong rally continues.

Should You Invest $1,000 in Eli Lilly and Company Right Now?Before you consider Eli Lilly and Company, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.

While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Nextracker (NXT - Free Report) ended the recent trading session at $78.34, demonstrating a +1.57% change from the preceding day's closing price. This change outpaced the S&P 500's 0.37% gain on the day. Elsewhere, the Dow lost 0.14%, while the tech-heavy Nasdaq added 0.71%.

Coming into today, shares of the solar energy equipment supplier had gained 10% in the past month. In that same time, the Oils-Energy sector gained 2.31%, while the S&P 500 gained 4.26%.

The investment community will be paying close attention to the earnings performance of Nextracker in its upcoming release. The company is slated to reveal its earnings on October 23, 2025. It is anticipated that the company will report an EPS of $0.98, marking a 1.03% rise compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $830.62 million, showing a 30.69% escalation compared to the year-ago quarter.

For the full year, the Zacks Consensus Estimates are projecting earnings of $4.09 per share and revenue of $3.34 billion, which would represent changes of -3.08% and +13.02%, respectively, from the prior year.

Any recent changes to analyst estimates for Nextracker should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.

Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.

The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.84% higher. Nextracker is currently a Zacks Rank #3 (Hold).

Looking at valuation, Nextracker is presently trading at a Forward P/E ratio of 18.88. This signifies a premium in comparison to the average Forward P/E of 16.91 for its industry.

One should further note that NXT currently holds a PEG ratio of 2.06. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As of the close of trade yesterday, the Solar industry held an average PEG ratio of 0.83.

The Solar industry is part of the Oils-Energy sector. Currently, this industry holds a Zacks Industry Rank of 36, positioning it in the top 15% of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.

In the latest close session, Novavax (NVAX - Free Report) was down 4.02% at $9.08. This move lagged the S&P 500's daily gain of 0.37%. At the same time, the Dow lost 0.14%, and the tech-heavy Nasdaq gained 0.71%.

Shares of the vaccine maker have appreciated by 19.75% over the course of the past month, outperforming the Medical sector's gain of 5.9%, and the S&P 500's gain of 4.26%.

Market participants will be closely following the financial results of Novavax in its upcoming release. It is anticipated that the company will report an EPS of -$0.26, marking a 65.79% rise compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $67 million, down 20.72% from the year-ago period.

NVAX's full-year Zacks Consensus Estimates are calling for earnings of $2.68 per share and revenue of $1.03 billion. These results would represent year-over-year changes of +317.89% and +51.52%, respectively.

Investors should also pay attention to any latest changes in analyst estimates for Novavax. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Novavax currently has a Zacks Rank of #3 (Hold).

In the context of valuation, Novavax is at present trading with a Forward P/E ratio of 3.53. This expresses a discount compared to the average Forward P/E of 19.52 of its industry.

Meanwhile, NVAX's PEG ratio is currently 0.12. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. Medical - Biomedical and Genetics stocks are, on average, holding a PEG ratio of 1.89 based on yesterday's closing prices.

The Medical - Biomedical and Genetics industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 79, positioning it in the top 32% of all 250+ industries.

The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

In the latest trading session, Alphabet (GOOGL - Free Report) closed at $250.43, marking a +2.07% move from the previous day. This change outpaced the S&P 500's 0.37% gain on the day. Meanwhile, the Dow experienced a drop of 0.14%, and the technology-dominated Nasdaq saw an increase of 0.71%.

Shares of the internet search leader witnessed a gain of 4.4% over the previous month, trailing the performance of the Computer and Technology sector with its gain of 8.04%, and outperforming the S&P 500's gain of 4.26%.

Investors will be eagerly watching for the performance of Alphabet in its upcoming earnings disclosure. The company is expected to report EPS of $2.29, up 8.02% from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $84.56 billion, showing a 13.42% escalation compared to the year-ago quarter.

GOOGL's full-year Zacks Consensus Estimates are calling for earnings of $9.96 per share and revenue of $334.66 billion. These results would represent year-over-year changes of +23.88% and +13.4%, respectively.

Investors should also take note of any recent adjustments to analyst estimates for Alphabet. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.34% decrease. At present, Alphabet boasts a Zacks Rank of #3 (Hold).

Investors should also note Alphabet's current valuation metrics, including its Forward P/E ratio of 24.64. This signifies a discount in comparison to the average Forward P/E of 24.7 for its industry.

One should further note that GOOGL currently holds a PEG ratio of 1.66. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Internet - Services was holding an average PEG ratio of 1.66 at yesterday's closing price.

The Internet - Services industry is part of the Computer and Technology sector. At present, this industry carries a Zacks Industry Rank of 84, placing it within the top 35% of over 250 industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.

Vancouver, BC, October 6, 2025 – TheNewswire - Eastfield Resources Ltd. (TSX-V: ETF) (“Eastfield” or the “Company “) announces that it has closed its previously announced non-brokered private placement for total proceeds of $1,000,000 (see news release dated August 25, 2025).  The private placement consisted of the sale of 50,000,000 units at a price of $0.02 per unit, with each unit consisting of one common share and one share purchase warrant, with each warrant entitling the holder to purchase an additional common share at a price of $0.05 until October 1, 2027.

All securities issued as part of the closing of this private placement, including any shares that may be issued pursuant to the exercise of the share purchase warrants, are subject to a hold period in Canada until February 2, 2026.

Eastfield paid a cash finder’s fee of $4,200 to Leede Financial Inc., of Vancouver, B.C. in connection with this private placement.

The proceeds from the sale of these units will be used by the Company to conduct exploration programs at its mineral projects in British Columbia (approximately 40% - 50%), for general working capital including payments to non-arm’s length parties for ongoing general administrative services (approximately 30% – 40%), and to investor relations activities (less than 10%).

Insiders of Eastfield purchased a total of 4,000,000 units in the private placement.  The participation of these insiders constituted a related party transaction within the meaning of TSX-V Policy 5.9 and Multilateral Instrument 61-101 – “Protection of Minority Security Holders in Special Transactions” (“MI 61-101”).  Eastfield has relied on exemptions from the formal valuation and minority shareholder approval requirements provided under sections 5.5(a) and 5.7(a) of MI 61-101 on the basis that the fair market value (as determined under MI 61-101) of insider participation in the private placement did not exceed 25% of Eastfield’s market capitalization.

For more information, please visit the Company’s website at www.eastfieldresources.com.

David M Douglas, CPA, CA.

CFO and Director

Contact: (604) 681-7913 or Toll Free: 888-656-6611

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Synchronoss (SNCR - Free Report) closed at $5.74 in the latest trading session, marking a -2.55% move from the prior day. This change lagged the S&P 500's 0.37% gain on the day. At the same time, the Dow lost 0.14%, and the tech-heavy Nasdaq gained 0.71%.

The stock of mobile services company has risen by 9.68% in the past month, leading the Computer and Technology sector's gain of 8.04% and the S&P 500's gain of 4.26%.

The upcoming earnings release of Synchronoss will be of great interest to investors. The company is forecasted to report an EPS of $0.31, showcasing a 219.23% upward movement from the corresponding quarter of the prior year. Meanwhile, the latest consensus estimate predicts the revenue to be $42.96 million, indicating stability compared to the same quarter of the previous year.

For the annual period, the Zacks Consensus Estimates anticipate earnings of $1.02 per share and a revenue of $172.32 million, signifying shifts of -37.42% and -0.73%, respectively, from the last year.

Investors might also notice recent changes to analyst estimates for Synchronoss. Recent revisions tend to reflect the latest near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Synchronoss presently features a Zacks Rank of #4 (Sell).

In the context of valuation, Synchronoss is at present trading with a Forward P/E ratio of 5.77. This signifies a discount in comparison to the average Forward P/E of 30.03 for its industry.

The Internet - Software industry is part of the Computer and Technology sector. With its current Zacks Industry Rank of 63, this industry ranks in the top 26% of all industries, numbering over 250.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.

Lithium Americas Corp. (LAC - Free Report) closed at $8.45 in the latest trading session, marking a -6.53% move from the prior day. This change lagged the S&P 500's 0.37% gain on the day. At the same time, the Dow lost 0.14%, and the tech-heavy Nasdaq gained 0.71%.

Heading into today, shares of the lithium producer had gained 212.8% over the past month, outpacing the Basic Materials sector's gain of 5.71% and the S&P 500's gain of 4.26%.

Market participants will be closely following the financial results of Lithium Americas Corp. in its upcoming release. It is anticipated that the company will report an EPS of -$0.05, marking a 400% fall compared to the same quarter of the previous year.

For the annual period, the Zacks Consensus Estimates anticipate earnings of -$0.21 per share and a revenue of $0 million, signifying shifts of 0% and 0%, respectively, from the last year.

Investors should also pay attention to any latest changes in analyst estimates for Lithium Americas Corp. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.

Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 6.33% lower. Currently, Lithium Americas Corp. is carrying a Zacks Rank of #3 (Hold).

The Mining - Miscellaneous industry is part of the Basic Materials sector. Currently, this industry holds a Zacks Industry Rank of 144, positioning it in the bottom 42% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

In the latest trading session, Medical Properties (MPW - Free Report) closed at $5.40, marking a -2.53% move from the previous day. This change lagged the S&P 500's daily gain of 0.37%. Meanwhile, the Dow experienced a drop of 0.14%, and the technology-dominated Nasdaq saw an increase of 0.71%.

Shares of the health care real estate investment trust have appreciated by 20.17% over the course of the past month, outperforming the Finance sector's gain of 2.07%, and the S&P 500's gain of 4.26%.

The upcoming earnings release of Medical Properties will be of great interest to investors. It is anticipated that the company will report an EPS of $0.16, marking stability compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $249.35 million, up 10.41% from the prior-year quarter.

MPW's full-year Zacks Consensus Estimates are calling for earnings of $0.63 per share and revenue of $945.01 million. These results would represent year-over-year changes of -21.25% and -5.08%, respectively.

It is also important to note the recent changes to analyst estimates for Medical Properties. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.

Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.

The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Medical Properties is currently a Zacks Rank #3 (Hold).

Looking at valuation, Medical Properties is presently trading at a Forward P/E ratio of 8.86. This expresses a discount compared to the average Forward P/E of 11.38 of its industry.

The REIT and Equity Trust - Other industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 142, finds itself in the bottom 43% echelons of all 250+ industries.

The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.